Connection

James Bearden to GABA-B Receptor Agonists

Back to Details
This is a "connection" page, showing publications James Bearden has written about GABA-B Receptor Agonists.
James Bearden
Connection Strength
0.022
GABA-B Receptor Agonists
  1. A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA. Support Care Cancer. 2011 Jun; 19(6):833-41.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.